Cumberland Pharmaceuticals Inc
Price
FilingsNewest: 8-K/A, Shareholder voteSep 11 →InsidersNo open-market buys or sales.→HoldersIkarian Capital 3.4%Renaissance Technologies 3.2%Vanguard 2.5%→Financing →PeersClosest companies: SUPN, INCY, UTHR→
From the filings
Figures
- Revenue
- $39.9Mlast 12 months
- Net income
- −$10.9Mlast 12 months
- Operating cash flow
- $1.4Mlast 12 months
- Cash and equivalents
- $3.9Mat the last balance sheet
- Total debt
- $0.00at the last balance sheet
- Shares outstanding
- 15.0M shareson issue